Gabelli Radio

  • Autor: Vários
  • Narrador: Vários
  • Editor: Podcast
  • Duración: 52:52:23
  • Mas informaciones

Informações:

Sinopsis

Gabelli Funds welcomes you to Gabelli Radio, where you can meet our portfolio managers & analysts, hear highlights from industry conferences, gain market insights, and learn more about our investment approaches. http://www.gabelli.com Invest with us 1-800-GABELLI (800-422-3554)

Episodios

  • U.S. Chips Act Update with Ryuta Makino

    19/04/2023 Duración: 02min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Ryuta Makino, a technology analyst at Gabelli Funds, gives an update on the U.S. Chips act. The U.S. Chips Act will provide $52 billion in manufacturing grants and research investments and establish a 25% investment tax credit to incentivize semiconductor manufacturing in the U.S. The global market share of U.S. semiconductor manufacturing has fallen from 37% in 1990 to 12% in 2022. The United States aims to bolster leading edge domestic semiconductor manufacturing in the midst of growing geopolitical tensions between the U.S. and China.

  • First Quarter 2023 Global Deal Recap

    17/04/2023 Duración: 03min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Chris Matthiessen, a member of our Merger Arbitrage investment team at Gabelli Funds, recaps the first quarter of 2023 global deals. Mergers and acquisitions activity remained subdued in the first quarter of 2023, totaling $580 billion globally, or a 44% decrease compared to a robust first quarter of 2022. A total of 12,700 deals were announced a global basis in the quarter, with about 28% or 3,500 announced in the United States, equating to a total value of $273 billion.

  • Warner Bros. Discovery 'Max' Launch Announcement

    17/04/2023 Duración: 03min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Paul Fanelli, a TMT analyst at Gabelli Funds, discusses Warner Brothers Discovery, and the announcement of its new streaming product, Max. This new service which launches on May 23, will replace HBO Max. The idea is to lean on the legacy of prestige content from HBO to attract subscribers, and to leverage the broad general entertainment offering from Discovery Plus to keep subscribers engaged and reduce churn.

  • Gabelli Fund's Mac Sykes Interviews Author Jacob McDonough about Berkshire Hathaway Book

    12/04/2023 Duración: 20min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Check out Gabelli Fund's Mac Sykes interview Author, Jacob McDonough, about his book on Berkshire Hathaway called "Capital Allocation: The Financials of a New England Textile Mill."

  • Best Ideas 2023: Heritage Crystal Clean [HCCI]

    11/04/2023 Duración: 02min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Michael Burgio, an Industrials Analyst at GAMCO Investors discusses Heritage Crystal Clean, his best idea for 2023. Heritage Crystal Clean is an environmental services operator that provides hazardous and non-hazardous waste disposal, emergency spill response, parts cleaning and used motor oil collection.

  • Energy Market Update and Halliburton

    06/04/2023 Duración: 04min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Simon Wong, Research Analyst covering the energy sector at Gabelli Funds, gives an update on the Energy Market and Halliburton. He discusses the recent announcement by Saudi Arabia who shocked the oil market by voluntarily cutting its production by 500,000 barrels per day beginning in May through December. This was just one day before a formal OPEC Plus JMMC meeting. The announcement was quickly followed by the UAE, Iraq, Kuwait, Algeria, Kazakhstan, Oman and Gabon. These cuts are voluntary and not a binding OPEC plus policy, so it can be reversed anytime.

  • Key Takeaways from NeoGenomics' Investor Day

    05/04/2023 Duración: 04min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Sara Wojda, Diagnostics & Life Sciences Analyst at Gabelli Funds, highlights the key takeaways from NeoGenomics’ Investor Day. NeoGenomics is a leading pure-play oncology testing company, offering an advanced and comprehensive testing menu to clinical and pharmaceutical customers globally. The company provided color into how it will be reshaping the business towards fast-growing products and markets, and will continue to be a leading cancer diagnostics player.

  • Convertible Market Update with James Dinsmore

    04/04/2023 Duración: 04min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) James Dinsmore, a Portfolio Manager focused on convertible strategies at Gabelli Funds, gives an update of the convertible market. His team has managed convertible securities through multiple market downturns and have seen how they can be a great tool for companies to raise capital despite uncertainty while offering investors a risk adjusted way to participate in a recovery. Historically, convertibles offer a compelling way to remain invested in equity markets and increase income while reducing downside participation. The current environment is unique, as it has given us an opportunity to increase the yield to maturity of our portfolios while maintaining some equity exposure in companies where we have high conviction.

  • On The Markets with Gabelli Funds' Charlie LaRosa: March 2023

    04/04/2023 Duración: 02min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Charlie LaRosa, Vice President of the Value team at Gabelli discusses our take "On the Markets" for February 2023. Growth stocks have substantially outperformed value stocks to start 2023. We believe this creates an opportunity for Value Investors. We continue to seek franchise businesses with barriers to entry, pricing power, recurring revenue and large free cash flow generation that are trading below Private Market Value. The environment remains ripe for value surfacing catalysts: while M&A activity was down in 2022, it is still robust compared to most historical years.

  • Orthopedic Market Update with Jennie Tsai

    04/04/2023 Duración: 03min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Jennie Tsai, the medical device analyst at Gabelli Funds, provides an update on the global orthopedic market. We believe 2023 revenue for most orthopedic companies will be above average as some of the backlog of elective procedures are worked through, companies continue to launch new products and hospital staffing challenges improves. This should result in operating margin improvement for most companies despite higher expenses with inflation and supply chain. Managements are working diligently to drive efficiency and improve margins.

  • Using Private Market Value and Catalyst to Surface Value

    03/04/2023 Duración: 02min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Anne Morrissy, Chartered Financial Analyst and member of the value team at GAMCO Asset Management, discusses how we use private market value and catalysts to surface value.

  • Utility Stocks - The Great Transformation

    31/03/2023 Duración: 02min

    Invest with Us 1-800-GABELLI (800-422-3554) Tim Winter, Portfolio Manager of the Gabelli Utilities Fund and long time Utilities Research Analyst highlights the value of the utilities sector. The sector is undergoing a great transformation from fossil fuels to clean energy. Electric gas and water utilities still have the same traditional defensive characteristics - monopolies, service areas, essential products, stable customer base, strong balance sheets, and strong credit ratings but now they have the added boost of political and regulatory support to achieve clean energy goals.

  • Caesars Entertainment (CZR) with Justin McAuliffe

    31/03/2023 Duración: 02min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Justin McAuliffe, a Research Analyst at Gabelli Funds covering the Gaming and Lodging industry, highlights Caesars Entertainment, which trades on the NASDAQ under the ticker CZR. He shares how Caesar Entertainment is a compelling long term value.

  • Tax Saving Qualified Charitable Distributions from your IRA - New Rules on Definition of “Charities”

    31/03/2023 Duración: 03min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Karen Fang, Managing Director, Wealth Management at GAMCO, discusses Tax Saving Qualified Charitable Distributions from your IRA and New Rules Expanding the Definition of “Charities”.

  • Music Industry Outlook with Hanna Howard

    30/03/2023 Duración: 04min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Hanna Howard, a Research Analyst focused on media at Gabelli Funds, discusses her outlook on the music industry, and highlights two names in particular that we continue to like longer-term – Universal Music Group (UMG) and Warner Music Group (WMG).

  • U.S. Sports Betting Market Update & Entain plc

    29/03/2023 Duración: 03min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Research Analyst at Gabelli Funds, Gustavo Pifano, shares an update on the U.S. Sports betting market and one of our best ideas for 2023, Entain plc. Nearly five years on since the US Supreme Court overturned the Professional and Amateur Sports Protection Act and allowed individual states to regulate and tax sports betting businesses, we now have legal sports betting in 33 states and Washington DC, representing just over 50% of the adult population.

  • Food Market Update with Sarah Donnelly

    29/03/2023 Duración: 02min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Gabelli Funds Portfolio Manager and Research Analyst, Sarah Donnelly discusses how the food industry tends to be less volatile and more resilient to economic downturns relative to many discretionary categories. This is only one of the reasons to invest in the industry. The primary growth driver over the last few years has been pricing following rampant input cost inflation related to substantial COVID demand, supply disruptions, supply constraints and crop concerns.

  • DFIN Multiple Avenues to Surface Value

    28/03/2023 Duración: 04min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Research Analyst at Gabelli Funds, Bart Rekucki, discusses an intriguing opportunity in Donnelley Financial Solutions, which we believe has multiple avenues to surface value. DFIN was spun off from RR Donnelley in 2016 in a tax free separation and is a major player in the market for financial reporting and compliance tools.

  • Gabelli Commercial Aerospace & Defense ETF "GCAD"

    27/03/2023 Duración: 03min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Tony Bancroft, the Aerospace and Defense analyst at GAMCO Investors and Portfolio Manager for Gabelli’s recently launched Commercial Aerospace and Defense ETF, ticker “GCAD" discusses secular and structural dynamics that should benefit the aerospace and defense industry over the long term.

  • Manchester United PLC (MANU) Strategic Alternatives Update with Andrew Cappucci

    24/03/2023 Duración: 02min

    http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554) Andrew Cappucci, a Research Analyst focused on sports and media at Gabelli Funds, provides an update on strategic alternatives for Manchester United PLC, which trades under the ticker MANU on the NYSE. Manchester United, headquartered in Manchester, England, is a UK-based soccer club.

página 14 de 20